Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.09676103 |
2 | vocalization behavior (GO:0071625) | 5.87698759 |
3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.48574973 |
4 | synaptic vesicle maturation (GO:0016188) | 5.43109844 |
5 | locomotory exploration behavior (GO:0035641) | 5.38631381 |
6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.38541776 |
7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.35971524 |
8 | neuron cell-cell adhesion (GO:0007158) | 5.27639320 |
9 | synaptic vesicle exocytosis (GO:0016079) | 5.24723600 |
10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.99100897 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.97308895 |
12 | protein localization to synapse (GO:0035418) | 4.92130548 |
13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.87477161 |
14 | glutamate secretion (GO:0014047) | 4.86049676 |
15 | cerebellar granule cell differentiation (GO:0021707) | 4.79811909 |
16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.60046084 |
17 | exploration behavior (GO:0035640) | 4.46739299 |
18 | layer formation in cerebral cortex (GO:0021819) | 4.38395204 |
19 | glutamate receptor signaling pathway (GO:0007215) | 4.38230255 |
20 | regulation of synaptic vesicle transport (GO:1902803) | 4.33209671 |
21 | synaptic transmission, glutamatergic (GO:0035249) | 4.28463748 |
22 | * neurotransmitter secretion (GO:0007269) | 4.27327578 |
23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.26591360 |
24 | proline transport (GO:0015824) | 4.23983639 |
25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.23178476 |
26 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.19294825 |
27 | neuron recognition (GO:0008038) | 4.17472150 |
28 | dendritic spine morphogenesis (GO:0060997) | 4.17292298 |
29 | neuronal action potential propagation (GO:0019227) | 4.15664197 |
30 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.06009125 |
31 | neuron-neuron synaptic transmission (GO:0007270) | 4.04002810 |
32 | regulation of synapse structural plasticity (GO:0051823) | 4.03011678 |
33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.92608310 |
34 | axonal fasciculation (GO:0007413) | 3.89372937 |
35 | gamma-aminobutyric acid transport (GO:0015812) | 3.83735621 |
36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.79400870 |
37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.77242786 |
38 | positive regulation of synapse maturation (GO:0090129) | 3.70414662 |
39 | L-amino acid import (GO:0043092) | 3.68661413 |
40 | transmission of nerve impulse (GO:0019226) | 3.68600194 |
41 | long-term memory (GO:0007616) | 3.68120055 |
42 | positive regulation of membrane potential (GO:0045838) | 3.67605003 |
43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.65639405 |
44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.62524546 |
45 | neuromuscular synaptic transmission (GO:0007274) | 3.62025150 |
46 | postsynaptic membrane organization (GO:0001941) | 3.60589499 |
47 | * neurotransmitter transport (GO:0006836) | 3.56381964 |
48 | cell differentiation in hindbrain (GO:0021533) | 3.52268107 |
49 | synaptic vesicle endocytosis (GO:0048488) | 3.48580779 |
50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.46759363 |
51 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.45969598 |
52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.44653818 |
53 | regulation of neurotransmitter secretion (GO:0046928) | 3.41176983 |
54 | dendrite morphogenesis (GO:0048813) | 3.40371996 |
55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.40013685 |
56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.38177378 |
57 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.37380815 |
58 | regulation of synaptic plasticity (GO:0048167) | 3.37002884 |
59 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.36903596 |
60 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.36857757 |
61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.35241212 |
62 | auditory behavior (GO:0031223) | 3.34109875 |
63 | cellular potassium ion homeostasis (GO:0030007) | 3.33997497 |
64 | cell migration in hindbrain (GO:0021535) | 3.32950314 |
65 | regulation of vesicle fusion (GO:0031338) | 3.32776993 |
66 | presynaptic membrane assembly (GO:0097105) | 3.32503139 |
67 | regulation of ARF protein signal transduction (GO:0032012) | 3.31396857 |
68 | activation of protein kinase A activity (GO:0034199) | 3.31066348 |
69 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.29609857 |
70 | * regulation of neurotransmitter levels (GO:0001505) | 3.29086335 |
71 | synapse assembly (GO:0007416) | 3.27929922 |
72 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.26633123 |
73 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26268760 |
74 | potassium ion homeostasis (GO:0055075) | 3.24576255 |
75 | neuromuscular process controlling balance (GO:0050885) | 3.24092995 |
76 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.23125391 |
77 | response to auditory stimulus (GO:0010996) | 3.22023940 |
78 | neuronal ion channel clustering (GO:0045161) | 3.21902577 |
79 | establishment of mitochondrion localization (GO:0051654) | 3.21099928 |
80 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.20609102 |
81 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.20181225 |
82 | chemosensory behavior (GO:0007635) | 3.20032828 |
83 | amino acid import (GO:0043090) | 3.19205120 |
84 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.18830808 |
85 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18797574 |
86 | * membrane depolarization (GO:0051899) | 3.18381313 |
87 | prepulse inhibition (GO:0060134) | 3.17637226 |
88 | response to histamine (GO:0034776) | 3.17622793 |
89 | long-term synaptic potentiation (GO:0060291) | 3.16533801 |
90 | membrane hyperpolarization (GO:0060081) | 3.16080751 |
91 | regulation of neurotransmitter transport (GO:0051588) | 3.15741239 |
92 | innervation (GO:0060384) | 3.14579616 |
93 | adult walking behavior (GO:0007628) | 3.13817148 |
94 | learning (GO:0007612) | 3.12628979 |
95 | * membrane depolarization during action potential (GO:0086010) | 3.11919110 |
96 | mechanosensory behavior (GO:0007638) | 3.10401387 |
97 | presynaptic membrane organization (GO:0097090) | 3.10083964 |
98 | cell communication by electrical coupling (GO:0010644) | 3.08848834 |
99 | social behavior (GO:0035176) | 3.08469641 |
100 | intraspecies interaction between organisms (GO:0051703) | 3.08469641 |
101 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.08320618 |
102 | behavioral defense response (GO:0002209) | 3.04760287 |
103 | behavioral fear response (GO:0001662) | 3.04760287 |
104 | neuromuscular process controlling posture (GO:0050884) | 3.04183995 |
105 | mitochondrion transport along microtubule (GO:0047497) | 3.02569051 |
106 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.02569051 |
107 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.99750190 |
108 | neuromuscular process (GO:0050905) | 2.98630275 |
109 | positive regulation of dendritic spine development (GO:0060999) | 2.98593761 |
110 | dendritic spine organization (GO:0097061) | 2.98280878 |
111 | vesicle transport along microtubule (GO:0047496) | 2.98273413 |
112 | potassium ion import (GO:0010107) | 2.98167076 |
113 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.98145154 |
114 | regulation of synapse maturation (GO:0090128) | 2.97746155 |
115 | cochlea development (GO:0090102) | 2.96805483 |
116 | * synaptic transmission (GO:0007268) | 2.96705052 |
117 | glycine transport (GO:0015816) | 2.96112953 |
118 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.95760679 |
119 | mating behavior (GO:0007617) | 2.95693707 |
120 | negative regulation of microtubule polymerization (GO:0031115) | 2.95640593 |
121 | synapse organization (GO:0050808) | 2.94651329 |
122 | sodium ion export (GO:0071436) | 2.94466062 |
123 | axon ensheathment in central nervous system (GO:0032291) | 2.92940653 |
124 | regulation of synaptic transmission (GO:0050804) | 2.92890144 |
125 | fear response (GO:0042596) | 2.92135144 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * EZH2_22144423_ChIP-Seq_EOC_Human | 5.68632610 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.74444248 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13441022 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11429246 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96848883 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75867715 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70160745 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70160745 |
9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65532139 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.60280914 |
11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59027156 |
12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52326552 |
13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49936359 |
14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46750945 |
15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46346143 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44849644 |
17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30944304 |
18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30937215 |
19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27568682 |
20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26485014 |
21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19093007 |
22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16353474 |
23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14157925 |
24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.10702753 |
25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.09650408 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09002483 |
27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93305089 |
28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91593101 |
29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88006483 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80975158 |
31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76374962 |
32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74775077 |
33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72573235 |
34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69579177 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67996166 |
36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61701133 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58831828 |
38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56765578 |
39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55631564 |
40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47208316 |
41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45086618 |
42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42634320 |
43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40000916 |
44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.39578747 |
45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37020792 |
46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35882509 |
47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35367947 |
48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34814473 |
49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34436845 |
50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34284647 |
51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34179463 |
52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33308594 |
53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32963436 |
54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28324313 |
55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27735027 |
56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26799083 |
57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26703224 |
58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26695125 |
59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26386156 |
60 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.25146300 |
61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24699604 |
62 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23828599 |
63 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23601894 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22833804 |
65 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.20261597 |
66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19045124 |
67 | * AR_19668381_ChIP-Seq_PC3_Human | 1.18417984 |
68 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.17464894 |
69 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15109822 |
70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14883011 |
71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14868090 |
72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12818028 |
73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12715726 |
74 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12547908 |
75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11069059 |
76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10618413 |
77 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10145633 |
78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09255653 |
79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09205451 |
80 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08705881 |
81 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08579597 |
82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08362552 |
83 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08248013 |
84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07983162 |
85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04567260 |
86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04333488 |
87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04333488 |
88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02802875 |
89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01855005 |
90 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01500297 |
91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01213591 |
92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00044317 |
93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99467207 |
94 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98710548 |
95 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97723011 |
96 | JUN_21703547_ChIP-Seq_K562_Human | 0.96452825 |
97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96221720 |
98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95293353 |
99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95265216 |
100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94429051 |
101 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94274175 |
102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93116188 |
103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92937048 |
104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92592186 |
105 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92021153 |
106 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91810608 |
107 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90589604 |
108 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90149132 |
109 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.88809959 |
110 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88178818 |
111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87739568 |
112 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87228615 |
113 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87030448 |
114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83729818 |
115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83580465 |
116 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.83149369 |
117 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81912362 |
118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81788415 |
119 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.78711499 |
120 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.75334564 |
121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.75046152 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.12540574 |
2 | MP0003880_abnormal_central_pattern | 4.82517014 |
3 | * MP0003635_abnormal_synaptic_transmissio | 4.04469834 |
4 | MP0004270_analgesia | 3.80442713 |
5 | * MP0009745_abnormal_behavioral_response | 3.33811644 |
6 | MP0001968_abnormal_touch/_nociception | 3.26737650 |
7 | * MP0002063_abnormal_learning/memory/cond | 3.25850776 |
8 | MP0005423_abnormal_somatic_nervous | 3.24286946 |
9 | MP0009046_muscle_twitch | 3.09022817 |
10 | MP0002064_seizures | 3.07470123 |
11 | * MP0002572_abnormal_emotion/affect_behav | 2.80623837 |
12 | * MP0002734_abnormal_mechanical_nocicepti | 2.74238814 |
13 | MP0002822_catalepsy | 2.73117357 |
14 | * MP0002272_abnormal_nervous_system | 2.56408763 |
15 | MP0002736_abnormal_nociception_after | 2.51504755 |
16 | * MP0002735_abnormal_chemical_nociception | 2.43095286 |
17 | * MP0001486_abnormal_startle_reflex | 2.42968127 |
18 | MP0001440_abnormal_grooming_behavior | 2.21378304 |
19 | * MP0002733_abnormal_thermal_nociception | 2.19062591 |
20 | MP0002184_abnormal_innervation | 2.12938369 |
21 | * MP0001501_abnormal_sleep_pattern | 2.09536772 |
22 | * MP0001970_abnormal_pain_threshold | 2.08412106 |
23 | MP0000778_abnormal_nervous_system | 2.07948506 |
24 | * MP0006276_abnormal_autonomic_nervous | 2.03139325 |
25 | MP0004858_abnormal_nervous_system | 2.01916001 |
26 | * MP0002067_abnormal_sensory_capabilities | 2.01100982 |
27 | * MP0002557_abnormal_social/conspecific_i | 1.84205247 |
28 | MP0004924_abnormal_behavior | 1.83738554 |
29 | MP0005386_behavior/neurological_phenoty | 1.83738554 |
30 | MP0004811_abnormal_neuron_physiology | 1.81643278 |
31 | MP0008569_lethality_at_weaning | 1.73918479 |
32 | MP0001984_abnormal_olfaction | 1.73908958 |
33 | MP0003329_amyloid_beta_deposits | 1.67795712 |
34 | MP0003879_abnormal_hair_cell | 1.67621625 |
35 | MP0009780_abnormal_chondrocyte_physiolo | 1.66311861 |
36 | MP0005646_abnormal_pituitary_gland | 1.65538603 |
37 | MP0000955_abnormal_spinal_cord | 1.63747265 |
38 | MP0003787_abnormal_imprinting | 1.60762122 |
39 | MP0002909_abnormal_adrenal_gland | 1.60541335 |
40 | MP0001529_abnormal_vocalization | 1.58592272 |
41 | MP0003123_paternal_imprinting | 1.52830435 |
42 | MP0002882_abnormal_neuron_morphology | 1.48721364 |
43 | * MP0002066_abnormal_motor_capabilities/c | 1.43404916 |
44 | MP0003122_maternal_imprinting | 1.43236342 |
45 | MP0001905_abnormal_dopamine_level | 1.39435970 |
46 | MP0001188_hyperpigmentation | 1.34588025 |
47 | MP0004885_abnormal_endolymph | 1.33988080 |
48 | MP0000569_abnormal_digit_pigmentation | 1.32920164 |
49 | MP0001502_abnormal_circadian_rhythm | 1.28595401 |
50 | * MP0005645_abnormal_hypothalamus_physiol | 1.26074977 |
51 | MP0004142_abnormal_muscle_tone | 1.24670877 |
52 | MP0003633_abnormal_nervous_system | 1.20460883 |
53 | MP0004742_abnormal_vestibular_system | 1.17670013 |
54 | MP0010386_abnormal_urinary_bladder | 1.17379731 |
55 | MP0002152_abnormal_brain_morphology | 1.15244205 |
56 | MP0008877_abnormal_DNA_methylation | 1.11452589 |
57 | MP0003631_nervous_system_phenotype | 1.07000753 |
58 | MP0002638_abnormal_pupillary_reflex | 1.01787745 |
59 | MP0008872_abnormal_physiological_respon | 1.00059585 |
60 | MP0002229_neurodegeneration | 0.98830055 |
61 | MP0005394_taste/olfaction_phenotype | 0.98662349 |
62 | MP0005499_abnormal_olfactory_system | 0.98662349 |
63 | MP0000537_abnormal_urethra_morphology | 0.98462949 |
64 | * MP0002069_abnormal_eating/drinking_beha | 0.96021736 |
65 | MP0000751_myopathy | 0.88625429 |
66 | MP0005167_abnormal_blood-brain_barrier | 0.88315627 |
67 | MP0002752_abnormal_somatic_nervous | 0.87763815 |
68 | MP0000631_abnormal_neuroendocrine_gland | 0.85632698 |
69 | MP0005551_abnormal_eye_electrophysiolog | 0.85496948 |
70 | MP0001963_abnormal_hearing_physiology | 0.85027937 |
71 | MP0008874_decreased_physiological_sensi | 0.83507587 |
72 | MP0003634_abnormal_glial_cell | 0.82825129 |
73 | MP0003632_abnormal_nervous_system | 0.79784060 |
74 | MP0001485_abnormal_pinna_reflex | 0.79246771 |
75 | MP0001177_atelectasis | 0.78540214 |
76 | MP0004145_abnormal_muscle_electrophysio | 0.78285709 |
77 | MP0005535_abnormal_body_temperature | 0.77474919 |
78 | * MP0004085_abnormal_heartbeat | 0.76849858 |
79 | MP0005409_darkened_coat_color | 0.73153204 |
80 | MP0005187_abnormal_penis_morphology | 0.71446355 |
81 | MP0000920_abnormal_myelination | 0.70122568 |
82 | MP0000604_amyloidosis | 0.69417960 |
83 | MP0002876_abnormal_thyroid_physiology | 0.69343270 |
84 | MP0003861_abnormal_nervous_system | 0.67442807 |
85 | MP0001664_abnormal_digestion | 0.67250223 |
86 | MP0001348_abnormal_lacrimal_gland | 0.66520730 |
87 | MP0002751_abnormal_autonomic_nervous | 0.66471380 |
88 | MP0003119_abnormal_digestive_system | 0.66287789 |
89 | MP0003283_abnormal_digestive_organ | 0.64616011 |
90 | MP0004510_myositis | 0.63001135 |
91 | MP0008961_abnormal_basal_metabolism | 0.62756839 |
92 | MP0001299_abnormal_eye_distance/ | 0.62382584 |
93 | MP0001986_abnormal_taste_sensitivity | 0.62111529 |
94 | MP0002837_dystrophic_cardiac_calcinosis | 0.61861080 |
95 | MP0002234_abnormal_pharynx_morphology | 0.61204810 |
96 | MP0004133_heterotaxia | 0.60843409 |
97 | MP0003121_genomic_imprinting | 0.58918036 |
98 | MP0003690_abnormal_glial_cell | 0.58836371 |
99 | MP0002249_abnormal_larynx_morphology | 0.58448580 |
100 | MP0001943_abnormal_respiration | 0.58355290 |
101 | MP0001346_abnormal_lacrimal_gland | 0.56878128 |
102 | * MP0010769_abnormal_survival | 0.55903821 |
103 | MP0004147_increased_porphyrin_level | 0.55735641 |
104 | MP0003698_abnormal_male_reproductive | 0.55626245 |
105 | * MP0010770_preweaning_lethality | 0.55325363 |
106 | * MP0002082_postnatal_lethality | 0.55325363 |
107 | MP0003137_abnormal_impulse_conducting | 0.55257709 |
108 | MP0000026_abnormal_inner_ear | 0.55210474 |
109 | MP0003878_abnormal_ear_physiology | 0.53707875 |
110 | MP0005377_hearing/vestibular/ear_phenot | 0.53707875 |
111 | MP0002090_abnormal_vision | 0.52499609 |
112 | * MP0010768_mortality/aging | 0.52457181 |
113 | MP0001944_abnormal_pancreas_morphology | 0.51673636 |
114 | MP0004484_altered_response_of | 0.51605017 |
115 | MP0004130_abnormal_muscle_cell | 0.50488115 |
116 | MP0004215_abnormal_myocardial_fiber | 0.50449933 |
117 | MP0000013_abnormal_adipose_tissue | 0.48985703 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.31163812 |
2 | Myokymia (HP:0002411) | 6.52198890 |
3 | Focal seizures (HP:0007359) | 5.83384130 |
4 | Visual hallucinations (HP:0002367) | 4.97654204 |
5 | Epileptic encephalopathy (HP:0200134) | 4.68651408 |
6 | Febrile seizures (HP:0002373) | 4.57398567 |
7 | Atonic seizures (HP:0010819) | 4.48182560 |
8 | Progressive cerebellar ataxia (HP:0002073) | 4.34458988 |
9 | Absence seizures (HP:0002121) | 4.07870709 |
10 | Supranuclear gaze palsy (HP:0000605) | 3.90158025 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.81575743 |
12 | Dialeptic seizures (HP:0011146) | 3.74505969 |
13 | Action tremor (HP:0002345) | 3.70429193 |
14 | Broad-based gait (HP:0002136) | 3.62265664 |
15 | Ankle clonus (HP:0011448) | 3.48811321 |
16 | Poor eye contact (HP:0000817) | 3.27975862 |
17 | Hyperventilation (HP:0002883) | 3.22619716 |
18 | Mutism (HP:0002300) | 3.22447133 |
19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.16348762 |
20 | Gaze-evoked nystagmus (HP:0000640) | 3.13659192 |
21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.13032695 |
22 | Amblyopia (HP:0000646) | 3.11878553 |
23 | Obstructive sleep apnea (HP:0002870) | 3.09108311 |
24 | Limb dystonia (HP:0002451) | 3.02681273 |
25 | Abnormal social behavior (HP:0012433) | 3.00718127 |
26 | Impaired social interactions (HP:0000735) | 3.00718127 |
27 | Truncal ataxia (HP:0002078) | 2.99196190 |
28 | Depression (HP:0000716) | 2.96599773 |
29 | Drooling (HP:0002307) | 2.96292930 |
30 | Excessive salivation (HP:0003781) | 2.96292930 |
31 | Abnormality of the corticospinal tract (HP:0002492) | 2.92766544 |
32 | Abnormal eating behavior (HP:0100738) | 2.84564007 |
33 | Progressive inability to walk (HP:0002505) | 2.83519905 |
34 | Dysmetria (HP:0001310) | 2.79990629 |
35 | Anxiety (HP:0000739) | 2.79545512 |
36 | Dysdiadochokinesis (HP:0002075) | 2.79156484 |
37 | Papilledema (HP:0001085) | 2.78726083 |
38 | Urinary urgency (HP:0000012) | 2.73528287 |
39 | Termporal pattern (HP:0011008) | 2.70637193 |
40 | Insidious onset (HP:0003587) | 2.70637193 |
41 | Genetic anticipation (HP:0003743) | 2.69682036 |
42 | Spastic gait (HP:0002064) | 2.67447281 |
43 | Cerebral inclusion bodies (HP:0100314) | 2.66636299 |
44 | Neurofibrillary tangles (HP:0002185) | 2.65225759 |
45 | Hemiparesis (HP:0001269) | 2.63763191 |
46 | Postural instability (HP:0002172) | 2.62740010 |
47 | Epileptiform EEG discharges (HP:0011182) | 2.52203028 |
48 | Impaired smooth pursuit (HP:0007772) | 2.51356452 |
49 | Diplopia (HP:0000651) | 2.50743570 |
50 | Abnormality of binocular vision (HP:0011514) | 2.50743570 |
51 | Polyphagia (HP:0002591) | 2.50204567 |
52 | Fetal akinesia sequence (HP:0001989) | 2.46566180 |
53 | Pheochromocytoma (HP:0002666) | 2.46314001 |
54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.43729996 |
55 | Torticollis (HP:0000473) | 2.42160195 |
56 | Absent speech (HP:0001344) | 2.40412335 |
57 | Stereotypic behavior (HP:0000733) | 2.39369539 |
58 | Annular pancreas (HP:0001734) | 2.38811782 |
59 | Abnormality of the lower motor neuron (HP:0002366) | 2.34441773 |
60 | Bradykinesia (HP:0002067) | 2.32500468 |
61 | Sleep apnea (HP:0010535) | 2.31544661 |
62 | Hypsarrhythmia (HP:0002521) | 2.31160888 |
63 | Dysmetric saccades (HP:0000641) | 2.28933170 |
64 | Agitation (HP:0000713) | 2.27907182 |
65 | Scanning speech (HP:0002168) | 2.24215917 |
66 | Inability to walk (HP:0002540) | 2.24006608 |
67 | Focal dystonia (HP:0004373) | 2.22728587 |
68 | Lower limb muscle weakness (HP:0007340) | 2.22672763 |
69 | Amyotrophic lateral sclerosis (HP:0007354) | 2.22079198 |
70 | Akinesia (HP:0002304) | 2.20801704 |
71 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20779182 |
72 | Protruding tongue (HP:0010808) | 2.19638500 |
73 | Tetraplegia (HP:0002445) | 2.14015992 |
74 | Inappropriate behavior (HP:0000719) | 2.11347857 |
75 | Intention tremor (HP:0002080) | 2.10619423 |
76 | Neuroendocrine neoplasm (HP:0100634) | 2.07789907 |
77 | Abnormality of salivation (HP:0100755) | 2.05082686 |
78 | Hemiplegia (HP:0002301) | 2.03021172 |
79 | Failure to thrive in infancy (HP:0001531) | 2.02729465 |
80 | Bronchomalacia (HP:0002780) | 2.02361191 |
81 | Spastic tetraparesis (HP:0001285) | 2.01268102 |
82 | Cerebral hypomyelination (HP:0006808) | 2.00894612 |
83 | Impaired vibratory sensation (HP:0002495) | 2.00812076 |
84 | Hypoventilation (HP:0002791) | 2.00772189 |
85 | Craniofacial dystonia (HP:0012179) | 2.00698551 |
86 | Hypoplasia of the brainstem (HP:0002365) | 2.00302642 |
87 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.00302642 |
88 | Status epilepticus (HP:0002133) | 1.96562698 |
89 | Blue irides (HP:0000635) | 1.90890534 |
90 | Gait imbalance (HP:0002141) | 1.90849853 |
91 | Neuronal loss in central nervous system (HP:0002529) | 1.90365106 |
92 | Generalized myoclonic seizures (HP:0002123) | 1.88714743 |
93 | Insomnia (HP:0100785) | 1.88695698 |
94 | Psychosis (HP:0000709) | 1.88164498 |
95 | Specific learning disability (HP:0001328) | 1.87647011 |
96 | Gait ataxia (HP:0002066) | 1.85402772 |
97 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.84865242 |
98 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.84865242 |
99 | Megalencephaly (HP:0001355) | 1.83512123 |
100 | Ventricular fibrillation (HP:0001663) | 1.82810174 |
101 | Prolonged QT interval (HP:0001657) | 1.82222999 |
102 | Exotropia (HP:0000577) | 1.82134101 |
103 | Clonus (HP:0002169) | 1.81704521 |
104 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81229165 |
105 | Lower limb amyotrophy (HP:0007210) | 1.80942900 |
106 | Incomplete penetrance (HP:0003829) | 1.79792175 |
107 | Aqueductal stenosis (HP:0002410) | 1.78378271 |
108 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.77402932 |
109 | Pointed chin (HP:0000307) | 1.76912290 |
110 | Abnormality of saccadic eye movements (HP:0000570) | 1.74694613 |
111 | Hepatoblastoma (HP:0002884) | 1.74122568 |
112 | Peripheral hypomyelination (HP:0007182) | 1.68260536 |
113 | Turricephaly (HP:0000262) | 1.66772059 |
114 | Choreoathetosis (HP:0001266) | 1.62971966 |
115 | Rigidity (HP:0002063) | 1.62728831 |
116 | Apathy (HP:0000741) | 1.62383684 |
117 | Spastic tetraplegia (HP:0002510) | 1.62340685 |
118 | Hypoplasia of the corpus callosum (HP:0002079) | 1.61019788 |
119 | Abnormal EKG (HP:0003115) | 1.58288135 |
120 | Delusions (HP:0000746) | 1.51880336 |
121 | Macroorchidism (HP:0000053) | 1.48843389 |
122 | Sporadic (HP:0003745) | 1.48499860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.56931299 |
2 | MARK1 | 4.17035487 |
3 | MAP3K9 | 3.75833889 |
4 | EPHA4 | 3.63752188 |
5 | MAP3K4 | 3.09043099 |
6 | CAMK1D | 2.90680774 |
7 | MINK1 | 2.72211082 |
8 | MAP2K7 | 2.59777747 |
9 | NTRK2 | 2.41978392 |
10 | DAPK2 | 2.36137765 |
11 | CASK | 2.23010557 |
12 | NTRK1 | 2.12625871 |
13 | PAK6 | 2.11132873 |
14 | MAP3K12 | 2.08441674 |
15 | SIK2 | 2.04343503 |
16 | MAP2K4 | 1.95613829 |
17 | MAPK13 | 1.83734391 |
18 | PNCK | 1.72490628 |
19 | TNIK | 1.71588632 |
20 | RIPK4 | 1.65450542 |
21 | KSR2 | 1.63381309 |
22 | CDK5 | 1.55203489 |
23 | GRK5 | 1.49252887 |
24 | KSR1 | 1.49123568 |
25 | DAPK1 | 1.46190440 |
26 | PRPF4B | 1.46033034 |
27 | CAMKK1 | 1.45288188 |
28 | PRKD3 | 1.44768653 |
29 | PLK2 | 1.29580924 |
30 | UHMK1 | 1.24079088 |
31 | PHKG1 | 1.20269313 |
32 | PHKG2 | 1.20269313 |
33 | PRKCG | 1.20141206 |
34 | LATS2 | 1.16246734 |
35 | INSRR | 1.16122906 |
36 | STK38 | 1.12899669 |
37 | FES | 1.04512135 |
38 | CAMK2A | 1.03630525 |
39 | CDK19 | 1.02704134 |
40 | SGK494 | 1.00783783 |
41 | SGK223 | 1.00783783 |
42 | MAP3K2 | 0.99595481 |
43 | PINK1 | 0.95189494 |
44 | ICK | 0.95157939 |
45 | TYRO3 | 0.95107551 |
46 | SIK3 | 0.92253345 |
47 | CSNK1G2 | 0.91763911 |
48 | SGK2 | 0.90523904 |
49 | CAMKK2 | 0.88858797 |
50 | CDK18 | 0.88142174 |
51 | CDK15 | 0.85831508 |
52 | STK11 | 0.84744557 |
53 | ARAF | 0.84357384 |
54 | CDK14 | 0.83812759 |
55 | CAMK1 | 0.82516589 |
56 | RET | 0.81138711 |
57 | CAMK2B | 0.80191512 |
58 | DYRK1A | 0.79770241 |
59 | MARK2 | 0.75100314 |
60 | CDK11A | 0.74281216 |
61 | PAK3 | 0.74066598 |
62 | CAMK1G | 0.71588795 |
63 | RIPK1 | 0.71331206 |
64 | MAP3K13 | 0.70749955 |
65 | SGK1 | 0.70294391 |
66 | SGK3 | 0.69445203 |
67 | WNK3 | 0.68787173 |
68 | AKT3 | 0.68345283 |
69 | FGFR2 | 0.67901669 |
70 | PRKCH | 0.66509308 |
71 | ALK | 0.64056756 |
72 | PRKD2 | 0.62883486 |
73 | TAOK1 | 0.62834515 |
74 | BRAF | 0.60360901 |
75 | OXSR1 | 0.59619789 |
76 | PTK2B | 0.59066981 |
77 | LMTK2 | 0.57898571 |
78 | NEK6 | 0.57553891 |
79 | FGR | 0.57345380 |
80 | BMPR2 | 0.56288195 |
81 | NME1 | 0.55835957 |
82 | PRKCZ | 0.55609793 |
83 | PRKCE | 0.55457817 |
84 | CDC42BPA | 0.51418480 |
85 | DYRK2 | 0.49273664 |
86 | FRK | 0.49160573 |
87 | MAP3K11 | 0.49127959 |
88 | PRKAA1 | 0.49087484 |
89 | PRKCI | 0.49067364 |
90 | RPS6KA2 | 0.47096251 |
91 | FYN | 0.46520469 |
92 | MAP3K6 | 0.46423002 |
93 | RPS6KA3 | 0.46343386 |
94 | ERBB3 | 0.45063973 |
95 | CSNK1G3 | 0.44765589 |
96 | CAMK2D | 0.44409268 |
97 | PKN1 | 0.44164338 |
98 | MAPK10 | 0.43893952 |
99 | MAPK8 | 0.43754192 |
100 | RAF1 | 0.43136811 |
101 | WNK1 | 0.42430394 |
102 | TNK2 | 0.42288670 |
103 | BCR | 0.41485914 |
104 | GSK3B | 0.40401716 |
105 | GRK7 | 0.40078310 |
106 | CAMK4 | 0.40029266 |
107 | CSNK1E | 0.39622896 |
108 | PDK1 | 0.39220182 |
109 | TRIB3 | 0.39112239 |
110 | CAMK2G | 0.38125153 |
111 | MAP2K1 | 0.37611030 |
112 | SCYL2 | 0.36513290 |
113 | PDPK1 | 0.36065718 |
114 | PRKCB | 0.36019369 |
115 | MAPK12 | 0.34950567 |
116 | BRSK1 | 0.34768787 |
117 | EEF2K | 0.34707983 |
118 | MAP3K1 | 0.34345367 |
119 | FER | 0.33443801 |
120 | ADRBK1 | 0.33255845 |
121 | IRAK2 | 0.33233422 |
122 | ERBB2 | 0.32548056 |
123 | PRKG1 | 0.31620147 |
124 | PRKDC | 0.28583437 |
125 | CDK12 | 0.27822628 |
126 | PRKCA | 0.27419540 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Nicotine addiction_Homo sapiens_hsa05033 | 3.88007717 |
2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26101871 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.75459008 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72714297 |
5 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70863314 |
6 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.68246542 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65878118 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.58979411 |
9 | * Morphine addiction_Homo sapiens_hsa05032 | 2.47553778 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45553631 |
11 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21715271 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.19930816 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 2.13229522 |
14 | Taste transduction_Homo sapiens_hsa04742 | 1.98618937 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 1.98576021 |
16 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.91672709 |
17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.88408192 |
18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.83380893 |
19 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.80985864 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80148163 |
21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.77423245 |
22 | Long-term depression_Homo sapiens_hsa04730 | 1.77409679 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.63731187 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62681897 |
25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.58642553 |
26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58194076 |
27 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56869545 |
28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49824353 |
29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43525851 |
30 | Axon guidance_Homo sapiens_hsa04360 | 1.39043807 |
31 | Gap junction_Homo sapiens_hsa04540 | 1.36608997 |
32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34604164 |
33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26385956 |
34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25915685 |
35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.24649652 |
36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23339697 |
37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14889816 |
38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14519286 |
39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13285662 |
40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10089873 |
41 | Glioma_Homo sapiens_hsa05214 | 1.08040553 |
42 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06454380 |
43 | Melanogenesis_Homo sapiens_hsa04916 | 1.03962729 |
44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99363434 |
45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95325537 |
46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94426915 |
47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90749295 |
48 | Phototransduction_Homo sapiens_hsa04744 | 0.87558523 |
49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86038499 |
50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85429436 |
51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83094231 |
52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82843833 |
53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80943917 |
54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79946719 |
55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75236609 |
56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72768636 |
57 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71806250 |
58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71783981 |
59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69598583 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69458067 |
61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68435116 |
62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66936352 |
63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66657894 |
64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65588731 |
65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64717935 |
66 | Alcoholism_Homo sapiens_hsa05034 | 0.60836289 |
67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58521767 |
68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58055666 |
69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55886218 |
70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55867190 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54830638 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54536827 |
73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53509593 |
74 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49127987 |
75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48470803 |
76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48056930 |
77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47732569 |
78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47278460 |
79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46587639 |
80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46237531 |
81 | Tight junction_Homo sapiens_hsa04530 | 0.45908584 |
82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45570838 |
83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44516946 |
84 | Endocytosis_Homo sapiens_hsa04144 | 0.44436509 |
85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44243372 |
86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42946337 |
87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42732702 |
88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41504651 |
89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40557270 |
90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39787214 |
91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39406247 |
92 | Prion diseases_Homo sapiens_hsa05020 | 0.38343428 |
93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38342310 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37110901 |
95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36257712 |
96 | Bile secretion_Homo sapiens_hsa04976 | 0.35218823 |
97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34933188 |
98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34382955 |
99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33073971 |
100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32709268 |
101 | ABC transporters_Homo sapiens_hsa02010 | 0.32312879 |
102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31783614 |
103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30303204 |
104 | Lysine degradation_Homo sapiens_hsa00310 | 0.29991923 |
105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28775428 |
106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28288658 |
107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28287828 |
108 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28089752 |
109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26141244 |
110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25482151 |
111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24501152 |
112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23916238 |
113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22094373 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19775179 |